Additionally, the RRs (relative risks) showed that high PTK6 expression had lower risk than low PTK6 expression, and that no cervical lymph node metastasis had lower risk than lymph node metastasis. The gene discussed is PTK6; the disease is metastatic malignant neoplasm in the lymph nodes.